BioXcel Therapeutics Inc Registered Shs WKN: A40YSR ISIN: US09075P2048 Forum: Aktien Thema: Hauptdiskussion

Wer deinen Kommentaren und deinem Bashing hier noch Glauben schenkt, dem ist nicht zu helfen... Ich bin drinnen, ich bin draußen, Insolvenz, Delisting,...

@Ernesto: zum 300 Mal ausgestiegen... schön langsam wird es lächerlich!

Besser gesagt wir dürfen nicht unter 2,4$ fallen .Dann droht verwässerung oder?

The Panel reviewed the Company’s compliance plan and strategies for achieving long-term compliance with the MVLS Requirement. On May 27, 2025, the Company received a decision letter from Nasdaq Stock Market LLC that the Panel has granted the Company’s request for an extension to regain compliance with the MVLS Requirement until September 16, 2025, subject to meeting certain interim conditions. On August 7, 2025, the Panel revised the terms of the extension pursuant to Nasdaq Listing Rule 5815(c)(4) following the Company not satisfying certain interim conditions. The Panel did note the positive developments related to the Company’s MVLS and that on the date of the extension the Company had already been in compliance with the MVLS Requirements and all other listing requirements for a number of days. Under the revised extension, the Company is required to continue maintaining compliance with the MVLS Requirement for each trading day until September 16, 2025. The Company intends to request the Panel reconsider the extended compliance requirement regarding the MVLS Requirements, but there is no assurance that the Panel will grant such request.

Bofa hat verkaufsemfehung abgegeben Ziel 1 Dollar